Accrued Expenses and Other Liabilities

12 Months Ended

Dec. 31, 2023

Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities

10.        Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following at:

	December 31,		December 31,
	2023		2022
Accrued marketing expenses	$	1,013,497	$	—
Other expenses		313,254		426,025
Accrued preclinical and clinical trial expenses		405,792		953,252
Compensation and related benefits		332,641		491,191
Accrued manufacturing expenses		97,877		6,133
Accrued franchise tax		38,800		40,000
	$	2,201,861	$	1,916,601